These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 22110389)

  • 1. Role of co-stimulation in Leishmaniasis.
    Tuladhar R; Natarajan G; Satoskar AR
    Int J Biol Sci; 2011; 7(9):1382-90. PubMed ID: 22110389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the immune responses involved in mediating protection or immunopathology during leishmaniasis.
    Pacheco-Fernandez T; Volpedo G; Verma C; Satoskar AR
    Biochem Soc Trans; 2021 Feb; 49(1):297-311. PubMed ID: 33449103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to master the host immune system? Leishmania parasites have the solutions!
    Rossi M; Fasel N
    Int Immunol; 2018 Mar; 30(3):103-111. PubMed ID: 29294040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the Role of Immune Checkpoints in Leishmaniasis.
    de Freitas E Silva R; von Stebut E
    Front Immunol; 2021; 12():620144. PubMed ID: 33776999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular and extracellular effector activity of mouse neutrophils in response to cutaneous and visceral Leishmania parasites.
    Valério-Bolas A; Pereira M; Alexandre-Pires G; Santos-Mateus D; Rodrigues A; Rafael-Fernandes M; Gabriel A; Passero F; Santos-Gomes G
    Cell Immunol; 2019 Jan; 335():76-84. PubMed ID: 30424873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunopathogenesis of Leishmania infections].
    Yurdakul P
    Mikrobiyol Bul; 2005 Jul; 39(3):363-81. PubMed ID: 16358498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major.
    Tuladhar R; Oghumu S; Dong R; Peterson A; Sharpe AH; Satoskar AR
    Exp Parasitol; 2015 Jan; 148():49-55. PubMed ID: 25447125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunomicrotope of Leishmania control and persistence.
    Bogdan C; Islam NA; Barinberg D; Soulat D; Schleicher U; Rai B
    Trends Parasitol; 2024 Sep; 40(9):788-804. PubMed ID: 39174373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subversion of host cell signalling by the protozoan parasite Leishmania.
    Gregory DJ; Olivier M
    Parasitology; 2005; 130 Suppl():S27-35. PubMed ID: 16281989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines in host-parasite interactions in leishmaniasis.
    Teixeira MJ; Teixeira CR; Andrade BB; Barral-Netto M; Barral A
    Trends Parasitol; 2006 Jan; 22(1):32-40. PubMed ID: 16310413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmaniasis: complexity at the host-pathogen interface.
    Kaye P; Scott P
    Nat Rev Microbiol; 2011 Jul; 9(8):604-15. PubMed ID: 21747391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines in Leishmaniasis: Map of cell movements highlights the landscape of infection and pathogenesis.
    de Araújo FF; Costa-Silva MF; Pereira AAS; Rêgo FD; Pereira VHS; de Souza JP; Fernandes LOB; Martins-Filho OA; Gontijo CMF; Peruhype-Magalhães V; Teixeira-Carvalho A
    Cytokine; 2021 Nov; 147():155339. PubMed ID: 33303311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunology of Leishmania infection and the implications for vaccine development.
    Vanloubbeeck Y; Jones DE
    Ann N Y Acad Sci; 2004 Oct; 1026():267-72. PubMed ID: 15604504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor signaling: a perspective to develop vaccine against leishmaniasis.
    Singh RK; Srivastava A; Singh N
    Microbiol Res; 2012 Sep; 167(8):445-51. PubMed ID: 22326459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of early neutrophil-Leishmania interactions on the host immune response to infection.
    Ribeiro-Gomes FL; Sacks D
    Front Cell Infect Microbiol; 2012; 2():59. PubMed ID: 22919650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi Infection.
    de Morais CG; Castro Lima AK; Terra R; dos Santos RF; Da-Silva SA; Dutra PM
    Biomed Res Int; 2015; 2015():324915. PubMed ID: 26090399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines and metabolic regulation: A framework of bidirectional influences affecting Leishmania infection.
    Bodhale N; Ohms M; Ferreira C; Mesquita I; Mukherjee A; André S; Sarkar A; Estaquier J; Laskay T; Saha B; Silvestre R
    Cytokine; 2021 Nov; 147():155267. PubMed ID: 32917471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity.
    Chang KP; Reed SG; McGwire BS; Soong L
    Acta Trop; 2003 Mar; 85(3):375-90. PubMed ID: 12659975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathways leading to interleukin-12 production and protective immunity in cutaneous leishmaniasis.
    Okwor I; Uzonna JE
    Cell Immunol; 2016 Nov; 309():32-36. PubMed ID: 27394077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of pathogenesis: differences amongst Leishmania species.
    Colmenares M; Kar S; Goldsmith-Pestana K; McMahon-Pratt D
    Trans R Soc Trop Med Hyg; 2002 Apr; 96 Suppl 1():S3-7. PubMed ID: 12055848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.